Michael MacLean
Chief Financial Officer and Chief Business Officer, Avidity Biosciences
Michael MacLean has more than 30 years of financial leadership experience and has been a key player in strategy and operations for high-growth companies. He currently serves as chief financial officer and chief business officer of Avidity Biosciences. Prior to Avidity, Michael held chief financial officer roles at Akcea Therapeutics and PureTech Health. Previously, he led Biogen’s worldwide finance operations. Michael is a former certified public accountant who practiced accounting for more than 18 years, during which time he served as a partner of Arthur Andersen LLP and KPMG International Limited.
Michael holds a B.S. in Accounting from Boston College.
Meet the rest of our
see all team members
Burt Adelman, M.D.
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
Bo Cumbo
President and Chief Executive Officer, Solid Biosciences
Sheila Mikhail, J.D.
Co-Founder and Former Chief Executive Officer, AskBio; Co-Founder and Chief Executive Officer, Jurata Thin Film
Joan Nickerson
Chief Administrative Officer
Kiran Musunuru, M.D., Ph.D.
Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Leslie Stolz, Ph.D.
Senior Vice President, Regulatory Affairs
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Broad Institute of MIT and Harvard
Yasser (Yas) El-Gamal, J.D.
Senior Vice President, Legal Affairs and Chief Intellectual Property Counsel
Barry Ticho, M.D., Ph.D.
Chief Medical Officer, Stoke Therapeutics
Eugene Braunwald, M.D.
Distinguished Hersey Professor of Medicine at Harvard Medical School
Jason Politi
Chief Technical Operations Officer
Lonnel Coats
Chief Executive Officer and Director, Lexicon Pharmaceuticals
Krishna Yeshwant, M.D.
Managing Partner, GV
Daniel J. Rader, M.D.
Chair, Department of Genetics, University of Pennsylvania
Andrew Geall, Ph.D.
Co-Founder and Chief Development Officer, Replicate Bioscience
Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer, Vertex Pharmaceuticals
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Allison Dorval
Chief Financial Officer
Jodie Morrison
Chief Executive Office and Director, Q32 Bio Inc.
Fred Fiedorek, M.D.
Chief Medical Officer
Troy Lister, Ph.D.
Chief Scientific Officer
J. Keith Joung, M.D., Ph.D.
Robert B. Colvin, M.D. Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Andrew Ashe, J.D.
President, Chief Operating Officer and General Counsel
